Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
18,035,411
-
Share change
-
-934,780
-
Total reported value
-
$247,630,024
-
Put/Call ratio
-
30%
-
Price per share
-
$13.73
-
Number of holders
-
68
-
Value change
-
-$13,779,022
-
Number of buys
-
27
-
Number of sells
-
35
Institutional Holders of KALA BIO INC COM NEW - Stock (KALA) as of Q2 2018
As of 30 Jun 2018,
KALA BIO INC COM NEW - Stock (KALA) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,035,411 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, WELLINGTON MANAGEMENT GROUP LLP, RA CAPITAL MANAGEMENT, LLC, Polaris Venture Management Co. V, L.L.C., TRV GP, LLC, Vivo Capital, LLC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, Broadfin Capital, LLC, and VANGUARD GROUP INC.
This page lists
68
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.